Monitoring Patients (cont.)
	At least monthly, evaluate for • Adherence to prescribed regimen • Signs and symptoms of active TB disease • Signs and symptoms of hepatitis (if receiving        isoniazid alone, and at 2, 4, and 8 weeks if        receiving RIF and PZA)